Search
for
Sort by
Research 30 of 1000+
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- IL-17 axis is a significant driver of skin inflammation in Card14 mutant pityriasis rubra pilaris model mice
- Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes
- Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- LB1667 Successful treatment of rare linear lichen planopilaris with ixekizumab
- Successful treatment of rare linear lichen planopilaris with Ixekizumab
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- IL-17a induces age-related olfactory dysfunction by impairing regeneration and promoting respiratory metaplasia in mice
- Successful treatment of palmoplantar pustular psoriasis with brodalumab
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Proinflammatory cytokines regulate epidermal stem cells in wound epithelialization
- Sycosis Barbae Treated With Bimekizumab
- A Novel Role of IL-17+ Cell Subsets in Ross River Virus-Induced Arthritic Disease
- Emerging Therapies for Acne Vulgaris
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- Type 2 innate immunity regulates hair follicle homeostasis to control <i>Demodex</i> pathosymbionts
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- 269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- IL-17-producing γδ T cells enhance bone regeneration